Replies to post #164482 on Biotech Values

[DewDiligence]

#msg-90335951 has the VRTX HCV news—comments welcome, but please don't post a duplicate of the news itself!

[oc631]

Here we go again—partial clinical hold for VX-135, VRTX's in-house nuke, due to elevated liver enzymes

The small studies never made sense in what should have been a very exciting drug. ACHN holders take note. At least VRTX was able to find partners to do oral combo testing with.